![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Oxford Genetics extends its CRISPR Gene Editing Technology License Agreement from ERS Genomics to...
Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery,...
Quicker, More Accurate Diagnoses for Dangerous Diseases and Genetic Disorders
Standfirst:There is growing awareness of the valuable role that diagnostics can play, both in the...
Looking Towards the Future: Worldwide Biosimilar Uptake and Pricing
What is a biosimilar?
Whereas generic drugs are identical copycats of small-molecule chemical products, biosimilars are...
Risking Addiction for Relief: Is There a Better Alternative to Opioids?
Every day, the United States loses 116 lives to the opioid epidemic.(1) Pharmacists are asking...
Process innovation needs to be undertaken in early R&D phase predicts ADC Bio
ADC Biotechnology (ADC Bio) predicts that the next crucial phase of innovation to optimise and...
Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab
Biogen and Neurimmune announced that Biogen has exercised its option to further reduce the previously...
A collaborative approach to innovation in Pharma
“IGNITE is a creative environment that fosters innovative thinking and encourages new ideas and enables...
Niche CDMO adds spray drying for highly potent drugs
IDIFARMA has announced new GMP spray drying capabilities which will make it one of the...
Roche’s Tecentriq shows positive results for lung-cancer treatment
Roche Holding AG (ROG.EB) said that a phase 3 IMpower150 study showed an improvement in...
Johnson & Johnson Human Performance Institute Invests $18 Million for future of Lake Nona...
The Johnson & Johnson Human Performance Institute today announced it is expanding its footprint in...